Elafibranor (Iqirvo) unveiled: a groundbreaking FDA-approved therapy revolutionizing primary biliary cholangitis treatment

Ann Med Surg (Lond). 2024 Oct 17;86(12):6910-6912. doi: 10.1097/MS9.0000000000002672. eCollection 2024 Dec.
No abstract available

Publication types

  • Editorial